BIRDSEYE THERAPEUTICS
Live / Applied — New application — not yet assigned to an examiner (as of 26 Jun 2026)
What this means for you
Not registered yet, but its 26 Jun 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99909103
- Mark type
- Word mark
- Filed
- 26 Jun 2026
- Attorney of record
- Joi A. White
Goods and services
- Class 042 — Scientific and technological services: Scientific research and development; medical research; biotechnology research; biomedical research services; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; pharmaceutical research services; product research and development; research and development services in the field of antibodies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research services relating to pharmaceuticals; drug discovery services; pharmaceutical drug development services; provision, identification and development of therapeutic proteins, antibodies, reagents, multi-specific biologics and multi-specific antibodies; providing information about medical and scientific research in the fields of pharmaceuticals; providing information about medical research; provision of information about clinical trials; providing medical and scientific research information in the field of clinical trials; provision of information in the fields of therapeutics, biotherapeutics, medicines, pharmaceuticals, and drugs; provision of information about proteins, therapeutic proteins, engineered proteins, antibodies, therapeutic antibodies, engineered antibodies, antibody therapies, and antibodies for medical use and purposes, multi-specific biologics, and multi-specific antibodies; providing a website featuring scientific information about therapeutics, biotherapeutics, pharmaceuticals, medicines, and drugs; providing a website featuring scientific information about proteins, therapeutic proteins, engineered proteins, antibodies, therapeutic antibodies, engineered antibodies, antibody therapies, and antibodies for medical use and purposes, multi-specific biologics, and multi-specific antibodies
Owner
- Birdseye Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 26 Jun 2026 — APPLICATION FILING RECEIPT MAILED
- 26 Jun 2026 — NEW APPLICATION ENTERED